|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cotignola J, Leonardi DB, Shahabi A, Acuña
AD, Stern MC, Navone N, Scorticati C, De Siervi A, Mazza O and
Vazquez E: Glutathione-S-transferase (GST) polymorphisms are
associated with relapse after radical prostatectomy. Prostate
Cancer Prostatic Dis. 16:28–34. 2013. View Article : Google Scholar :
|
|
3
|
Isaacs JT, Schulze H and Coffey DS:
Development of androgen resistance in prostatic cancer. Prog Clin
Biol Res. 243A:21–31. 1987.PubMed/NCBI
|
|
4
|
Han M, Partin AW, Zahurak M, Piantadosi S,
Epstein JI and Walsh PC: Biochemical (prostate specific antigen)
recurrence probability following radical prostatectomy for
clinically localized prostate cancer. J Urol. 169:517–523. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight. Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar :
|
|
10
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Adams BD, Kasinski AL and Slack FJ:
Aberrant regulation and function of microRNAs in cancer. Curr Biol.
24:R762–R776. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Calin GA, Dumitru CD, Shimizu M, Bichi R,
Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, et al:
Frequent deletions and down-regulation of micro- RNA genes miR15
and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad
Sci USA. 99:15524–15529. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garzon R, Calin GA and Croce CM: MicroRNAs
in Cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ma J, Dong C and Ji C: MicroRNA and drug
resistance. Cancer Gene Ther. 17:523–531. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wach S, Nolte E, Szczyrba J, Stöhr R,
Hartmann A, Ørntoft T, Dyrskjøt L, Eltze E, Wieland W, Keck B, et
al: MicroRNA profiles of prostate carcinoma detected by
multiplatform microRNA screening. Int J Cancer. 130:611–621. 2012.
View Article : Google Scholar
|
|
16
|
Szczyrba J, Löprich E, Wach S, Jung V,
Unteregger G, Barth S, Grobholz R, Wieland W, Stöhr R, Hartmann A,
et al: The microRNA profile of prostate carcinoma obtained by deep
sequencing. Mol Cancer Res. 8:529–538. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schaefer A, Jung M, Mollenkopf HJ, Wagner
I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G and Jung
K: Diagnostic and prognostic implications of microRNA profiling in
prostate carcinoma. Int J Cancer. 126:1166–1176. 2010.
|
|
18
|
Ambs S, Prueitt RL, Yi M, Hudson RS, Howe
TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, et al:
Genomic profiling of microRNA and messenger RNA reveals deregulated
microRNA expression in prostate cancer. Cancer Res. 68:6162–6170.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Szczyrba J, Nolte E, Wach S, Kremmer E,
Stöhr R, Hartmann A, Wieland W, Wullich B and Grässer FA:
Downregulation of Sec23A protein by miRNA-375 in prostate
carcinoma. Mol Cancer Res. 9:791–800. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Brown DM and Ruoslahti E: Metadherin, a
cell surface protein in breast tumors that mediates lung
metastasis. Cancer Cell. 5:365–374. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Su ZZ, Kang DC, Chen Y, Pekarskaya O, Chao
W, Volsky DJ and Fisher PB: Identification and cloning of human
astrocyte genes displaying elevated expression after infection with
HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid
subtraction hybridization, RaSH. Oncogene. 21:3592–3602. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li JW, Huang CZ, Li JH, Yuan JH, Chen QH,
Zhang WF, Xu ZS, Liu YP, Li Y, Zhan MX, et al: Knockdown of
metadherin inhibits cell proliferation and migration in colorectal
cancer. Oncol Rep. 40:2215–2223. 2018.PubMed/NCBI
|
|
23
|
Chen X, Li XY, Long M, Wang X, Gao ZW, Cui
Y, Ren J, Zhang Z, Liu C, Dong K, et al: The FBXW7 tumor suppressor
inhibits breast cancer proliferation and promotes apoptosis by
targeting MTDH for degradation. Neoplasma. 65:201–209. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen Y, Wu H, Wang X, Wang C, Gan L, Zhu
J, Tong J and Li Z: Huaier Granule extract inhibit the
proliferation and metastasis of lung cancer cells through
down-regulation of MTDH, JAK2/STAT3 and MAPK signaling pathways.
Biomed Pharmacother. 101:311–321. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ma Z, Chen Y, Dong S, Xu X, Liu J, Song P,
Yu C and Dai L: AEG-1 mRNA expression in non-small cell lung cancer
is associated with increased tumor angiogenesis. Pathol Res Pract.
213:1257–1263. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Huang LL, Wang Z, Cao CJ, Ke ZF, Wang F,
Wang R, Luo CQ, Lu X and Wang LT: AEG-1 associates with metastasis
in papillary thyroid cancer through upregulation of MMP2/9. Int J
Oncol. 51:812–822. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yin Q, Han Y, Zhu D, Li Z, Shan S, Jin W,
Lu Q and Ren T: miR-145 and miR-497 suppress TGF-β-induced
epithelial-mesenchymal transition of non-small cell lung cancer by
targeting MTDH. Cancer Cell Int. 18:1052018. View Article : Google Scholar
|
|
28
|
Chen Z, Ma Y, Pan Y, Zhu H, Yu C and Sun
C: MiR-1297 suppresses pancreatic cancer cell proliferation and
metastasis by targeting MTDH. Mol Cell Probes. 40:19–26. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fan N, Zhang J, Cheng C, Zhang X, Feng J
and Kong R: MicroRNA-384 represses the growth and invasion of
non-small-cell lung cancer by targeting astrocyte elevated
gene-1/Wnt signaling. Biomed Pharmacother. 95:1331–1337. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Qiao W, Cao N and Yang L: MicroRNA-154
inhibits the growth and metastasis of gastric cancer cells by
directly targeting MTDH. Oncol Lett. 14:3268–3274. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Abrahante JE, Daul AL, Li M, Volk ML,
Tennessen JM, Miller EA and Rougvie AE: The Caenorhabditis elegans
hunchback-like gene lin-57/hbl-1 controls developmental time and is
regulated by microRNAs. Dev Cell. 4:625–637. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
34
|
Gu C, Feng L, Peng H, Yang H, Feng Z and
Yang Y: MTDH is an oncogene in multiple myeloma, which is
suppressed by Bortezomib treatment. Oncotarget. 7:4559–4569. 2016.
View Article : Google Scholar :
|
|
35
|
Noch EK and Khalili K: The role of
AEG-1/MTDH/LYRIC in the pathogenesis of central nervous system
disease. Adv Cancer Res. 120:159–192. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li J, Zhang N, Song LB, Liao WT, Jiang LL,
Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS and Li M: Astrocyte
elevated gene-1 is a novel prognostic marker for breast cancer
progression and overall patient survival. Clin Cancer Res.
14:3319–3326. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu L, Wu J, Ying Z, Chen B, Han A, Liang
Y, Song L, Yuan J, Li J and Li M: Astrocyte elevated gene-1
upregulates matrix metalloproteinase-9 and induces human glioma
invasion. Cancer Res. 70:3750–3759. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yu C, Chen K, Zheng H, Guo X, Jia W, Li M,
Zeng M, Li J and Song L: Overexpression of astrocyte elevated
gene-1 (AEG-1) is associated with esophageal squamous cell
carcinoma (ESCC) progression and pathogenesis. Carcinogenesis.
30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Song L, Li W, Zhang H, Liao W, Dai T, Yu
C, Ding X, Zhang L and Li J: Over-expression of AEG-1 significantly
associates with tumour aggressiveness and poor prognosis in human
non-small cell lung cancer. J Pathol. 219:317–326. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Emdad L, Sarkar D, Su ZZ, Randolph A,
Boukerche H, Valerie K and Fisher PB: Activation of the nuclear
factor kappaB pathway by astrocyte elevated gene-1: Implications
for tumor progression and metastasis. Cancer Res. 66:1509–1516.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li C, Wu X, Zhang W, Li J, Liu H, Hao M,
Wang J, Zhang H, Yang G, Hao M, et al: AEG-1 Promotes Metastasis
Through Downstream AKR1C2 and NF1 in Liver Cancer. Oncol Res.
22:203–211. 2014. View Article : Google Scholar
|
|
42
|
Liu DC and Yang ZL: MTDH and EphA7 are
markers for metastasis and poor prognosis of gallbladder
adenocarcinoma. Diagn Cytopathol. 41:199–205. 2013. View Article : Google Scholar
|
|
43
|
Hu G, Chong RA, Yang Q, Wei Y, Blanco MA,
Li F, Reiss M, Au JL, Haffty BG and Kang Y: MTDH activation by 8q22
genomic gain promotes chemoresistance and metastasis of
poor-prognosis breast cancer. Cancer Cell. 15:9–20. 2009.
View Article : Google Scholar :
|
|
44
|
Fuse M, Kojima S, Enokida H, Chiyomaru T,
Yoshino H, Nohata N, Kinoshita T, Sakamoto S, Naya Y, Nakagawa M,
et al: Tumor suppressive microRNAs (miR-222 and miR-31) regulate
molecular pathways based on microRNA expression signature in
prostate cancer. J Hum Genet. 57:691–699. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Porkka KP, Pfeiffer MJ, Waltering KK,
Vessella RL, Tammela TL and Visakorpi T: MicroRNA expression
profiling in prostate cancer. Cancer Res. 67:6130–6135. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tong AW, Fulgham P, Jay C, Chen P, Khalil
I, Liu S, Senzer N, Eklund AC, Han J and Nemunaitis J: MicroRNA
profile analysis of human prostate cancers. Cancer Gene Ther.
16:206–216. 2009. View Article : Google Scholar
|
|
47
|
Wang Q, Lv L, Li Y and Ji H: MicroRNA 655
suppresses cell proliferation and invasion in oral squamous cell
carcinoma by directly targeting metadherin and regulating the
PTEN/AKT pathway. Mol Med Rep. 18:3106–3114. 2018.PubMed/NCBI
|
|
48
|
Matsushita R, Yoshino H, Enokida H, Goto
Y, Miyamoto K, Yonemori M, Inoguchi S, Nakagawa M and Seki N:
Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145
(miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell
aggressiveness. Oncotarget. 7:28460–28487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Misono S, Seki N, Mizuno K, Yamada Y,
Uchida A, Arai T, Kumamoto T, Sanada H, Suetsugu T and Inoue H:
Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p)
regulate oncogenes in lung adenocarcinoma pathogenesis. J Hum
Genet. 63:1015–1028. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mataki H, Seki N, Mizuno K, Nohata N,
Kamikawaji K, Kumamoto T, Koshizuka K, Goto Y and Inoue H:
Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and
miR-145-3p) coordinately targeted MTDH in lung squamous cell
carcinoma. Oncotarget. 7:72084–72098. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Ozen M, Karatas OF, Gulluoglu S, Bayrak
OF, Sevli S, Guzel E, Ekici ID, Caskurlu T, Solak M, Creighton CJ,
et al: Overexpression of miR-145-5p inhibits proliferation of
prostate cancer cells and reduces SOX2 expression. Cancer Invest.
33:251–258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Goto Y, Kurozumi A, Arai T, Nohata N,
Kojima S, Okato A, Kato M, Yamazaki K, Ishida Y, Naya Y, et al:
Impact of novel miR-145-3p regulatory networks on survival in
patients with castration-resistant prostate cancer. Br J Cancer.
117:409–420. 2017. View Article : Google Scholar : PubMed/NCBI
|
